FDA studies effects of RFID on implantable devices

03/24/2008 | Medical Devices Today

Engineers at the FDA's Center for Devices and Radiological Health are looking into the possible effects of radio-frequency identification systems on pacemakers and implantable cardioverter defibrillators. RFID interference is "a potential problem" that has not been "completely characterized at this point," an AdvaMed official said. The test procedure could help device makers and RFID manufacturers develop safer products, the lead investigator said.

View Full Article in:

Medical Devices Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY